Erratum to: Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain
- Daniela Impellizzeri†1,
- Giuseppe Bruschetta†1,
- Marika Cordaro1,
- Rosalia Crupi1,
- Rosalba Siracusa1,
- Emanuela Esposito1 and
- Salvatore Cuzzocrea1, 2Email author
© The Author(s). 2016
Received: 24 May 2016
Accepted: 24 May 2016
Published: 31 May 2016
The original article was published in Journal of Neuroinflammation 2014 11:136
The authors would like to issue an erratum for this article , and would like to declare the following competing interests which we inadvertently failed to include in our original publication. The authors would like to apologise for this omission.
EP 2 821 083
No other authors have competing interests.
Ethics approval and consent to participate
The study  was approved by the University of Messina Animal Care Review Board: protocol number 8/U-apr 16.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Impellizzeri D, Bruschetta G, Cordaro M, Crupi R, Siracusa R, Esposito E, Cuzzocrea S. Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain. J Neuroinflammation. 2014;11:136. doi:https://doi.org/10.1186/s12974-014-0136-0.View ArticlePubMedPubMed CentralGoogle Scholar